Skip to content

Clinical trials

Phase 2 Bronchial Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Diseases Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20121
20171
20181
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Upstream Bio Inc.2
Altair Therapeutics, Inc.1
Deciphera Pharmaceuticals, LLC1
Hopital Foch1
Novartis Pharmaceuticals1
Pfizer1
Whanin Pharmaceutical Company1
Windward Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Diseases11
Asthma9
Lung Diseases9
Respiratory Tract Diseases9
Lung Diseases, Obstructive6
Immune System Diseases3
Respiratory Hypersensitivity3
Bronchiolitis Obliterans Syndrome2
Hypersensitivity2
Hypersensitivity, Immediate2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.